Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2010

01-03-2010 | Case Report

Autoimmune Hepatitis as a Part of Polyglandular Autoimmune Syndrome Type II: Case Report and Literature Review

Authors: Trushar Patel, Jacquelyn Nystrom, Nikolaos Pyrsopoulos

Published in: Digestive Diseases and Sciences | Issue 3/2010

Login to get access

Excerpt

A 48-year-old Caucasian man was admitted for fatigue, abdominal discomfort, and jaundice. His history showed 10 pounds weight loss, dark urine, and light-colored stool for 2 weeks prior to admission. Five days prior to admission he began to experience marked decrease in appetite and abdominal discomfort. He decided to perform an internet search and the word “jaundice” was mentioned very frequently. At this point he noticed the yellow hue of his skin and he visited his primary-care physician who directed the patient to the emergency room. The laboratory evaluation revealed acute hepatitis and he was admitted for further evaluation. His past medical history was significant for autoimmune diabetes diagnosed 2 years ago. He was found to be at low risk for viral hepatitis from social, sexual, and travel history. He refrained from alcohol use. Medications prior to admission were metformin, ramipril, aspirin, and multivitamin, but no alternative or herbal medications. On physical examination he was noted to be icteric, his thyroid gland was nontender and normal sized, and his abdomen was soft with no palpable hepatomegaly or Murphy’s sign. …
Literature
1.
go back to reference Pereira BJG, Dash RJ, Sehgal S, Sakhuja V, Chugh KS. Type-II polyglandular autoimmune syndrome. JAPI. 1986;34. Pereira BJG, Dash RJ, Sehgal S, Sakhuja V, Chugh KS. Type-II polyglandular autoimmune syndrome. JAPI. 1986;34.
2.
go back to reference Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. 2003;74(1):9–33.PubMed Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS). Acta Biomed. 2003;74(1):9–33.PubMed
4.
go back to reference F Magitta N, Pura M, Bøe Wolff SA, et al. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison’s disease. Eur J Endocrinol. 2008;158(5):705–709. doi:10.1530/EJE-07-0843.CrossRefPubMed F Magitta N, Pura M, Bøe Wolff SA, et al. Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison’s disease. Eur J Endocrinol. 2008;158(5):705–709. doi:10.​1530/​EJE-07-0843.CrossRefPubMed
11.
go back to reference Wolf DC, Raghuraman UV. Autoimmune hepatitis. Emedicine. 2008 (July 31). Wolf DC, Raghuraman UV. Autoimmune hepatitis. Emedicine. 2008 (July 31).
12.
go back to reference Obermayer-Straub P, Strassburg CP, Manns MP. Target proteins in human autoimmunity: cytochromes P450 and UDP-glucuronosyltransferases. Can J Gastroenterol. 2000;14(5):429–439.PubMed Obermayer-Straub P, Strassburg CP, Manns MP. Target proteins in human autoimmunity: cytochromes P450 and UDP-glucuronosyltransferases. Can J Gastroenterol. 2000;14(5):429–439.PubMed
13.
go back to reference Vogel A, Liermann H, Harms A, Strassburg CP, Manns MP, Obermayer-Straub P. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology. 2001;33(5):1047–1052. doi:10.1053/jhep.2001.24031.CrossRefPubMed Vogel A, Liermann H, Harms A, Strassburg CP, Manns MP, Obermayer-Straub P. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1. Hepatology. 2001;33(5):1047–1052. doi:10.​1053/​jhep.​2001.​24031.CrossRefPubMed
Metadata
Title
Autoimmune Hepatitis as a Part of Polyglandular Autoimmune Syndrome Type II: Case Report and Literature Review
Authors
Trushar Patel
Jacquelyn Nystrom
Nikolaos Pyrsopoulos
Publication date
01-03-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0796-2

Other articles of this Issue 3/2010

Digestive Diseases and Sciences 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine